ABO genotyping of complete hydatidiform moles.

doi:10.1155/1993/750349

Back to search

Article

ABO genotyping of complete hydatidiform moles.

Disease markers - 1 Nov 1993

Fisher R A, Johnson P H, Povey S, Hopkinson D A, Lawler S D

Abstract excerpt

It has been suggested that the ABO blood group of a patient and her partner influence the clinical outcome for patients having a pregnancy with a complete hydatidiform mole (CHM). Since CHM lack red blood cells, it has not previously been possible to type CHM serologically and investigate the relationship between the blood group of the CHM and that of the patient. In the present study we have demonstrated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hydatidiform Mole

Share to Parents

Share to Phenotype

Share to Polymerase Chain Reaction

Share to Pregnancy

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 8 closest

ABO genotyping of complete hydatidiform moles.PMID 8112022Read

Amniotic tissue in complete hydatidiform moles can be androgenetic.Semantic proximity Read

Blood type and ovarian reserveSemantic proximity Read

ABO BLOOD GROUP GENOTYPES IN WOMEN WITH BREAST CANCER.Semantic proximity Read

Rapid ABO genotyping using whole blood without DNA purification.Semantic proximity Read

Molecular genetic analysis of complete hydatidiform moles.Semantic proximity Read

Molecular genetics and genomics of the ABO blood group systemSemantic proximity Read

Blood group genotypingSemantic proximity Read

A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles.Semantic proximity Read